ARCHIVES

November issue of Business & Regulatory Report, an additional 8 pages, included in this issue.

This article is from The Cancer Letter archive.

Vol. 30 No. 44 | November 19, 2004

Download PDF Visit The Full Archive

Related Articles

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

June 3, 2005

In Brief: XIIIth Congress Draws Record Number Of Abstracts, 3,000 Registrants So Far; Exhibit Area Sold Out

March 5, 1982

Stand Up To Cancer Awards 13 Grants

January 15, 2010

In Brief: Cooper Wouldn’t Take NIH Job, Says No One Has Asked Him To Take Top Health Spot

February 7, 1975

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

April 26, 2013

DCCR Free Up $5 Million; New Policy Limits Core Support

November 5, 1976